These data suggest that chondromas and chondrosarcomas should be considered as being at opposite ends of the pathologic spectrum from benign to malignant tumors, and that somatic IDH mutations are suggested to be early events in malignant transformation [40]. This evidence concerns the gene IDH1 and chondrosarcoma.